Serum NY-ESO-1 and p53 antibodies as useful tumor markers in gastric cancer.
Junji KawadaTakuro SaitoYukinori KurokawaRyohei KawabataAtsushi TakenoTomohira TakeokaYohei NoseHisashi WadaHidetoshi EguchiYuichiro Dokinull nullPublished in: Annals of gastroenterological surgery (2023)
The combination of NY-ESO-1 and p53 antibody responses to CEA and CA19-9 increases the diagnostic accuracy of gastric cancer. Serum NY-ESO-1 and p53 antibodies may be useful tumor markers for gastric cancer.
Keyphrases